Captrust Financial Advisors Navidea Biopharmaceuticals, Inc. Transaction History

Captrust Financial Advisors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.0 - $1.82 $150 - $273	-150 Reduced 97.4%	4 $0
Q3 2021 Nov 16, 2021	BUY	$1.53 - $1.85 $229 - $277	150 Added 3750.0%	154 $0
Q2 2020 Aug 14, 2020	BUY	$0.7 - $4.16 $2 - $16	4 New	4 $0
Q4 2019 Feb 14, 2020	SELL	$0.65 - $1.26 $2 - $5	-4 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$0.5 - $0.91 $2 - $3	4 New	4 $0

10.4K

Ticker NAVB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,150,900
Description
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expr...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.